1. Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials. (8th May 2020) Authors: Saba, Corey F.; Clifford, Craig; Burgess, Kristine; Phillips, Brenda; Vail, David; Wright, Zachary; Curran, Katie; Fan, Timothy; Elmslie, Robyn; Post, Gerald; Thamm, Douglas Journal: Veterinary and comparative oncology Issue: Volume 18:Number 4(2020:Dec.) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B‐cell lymphoma treated with a 19‐week CHOP protocol. (25th November 2019) Authors: Wolf‐Ringwall, Amber; Lopez, Lynelle; Elmslie, Robyn; Fowler, Brooke; Lori, Janet; Sfiligoi, Gabriella; Skope, Anne; Arnold, Erin; Hughes, Kelly L.; Thamm, Douglas H.; Ehrhart, E. J.; Avery, Anne C.; Lana, Susan E. Journal: Veterinary and comparative oncology Issue: Volume 18:Number 3(2020:Sep.) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer stem cell populations in lymphoma in dogs and impact of cytotoxic chemotherapy. (21st October 2018) Authors: Hartley, Genevieve; Elmslie, Robyn; Murphy, Brent; Hopkins, Leone; Guth, Amanda; Dow, Steven Journal: Veterinary and comparative oncology Issue: Volume 17:Number 1(2019:Mar.) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗